Clinically Meaningful Outcomes Among Expanding Treatment Options In Rcc

Clinically Meaningful Outcomes Among Expanding Treatment Options in RCC

PeerView Oncology

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy Options

PeerView Oncology

Guidelines Based Management of Localized and Locally Advanced RCC

Grand Rounds in Urology

Treatment Options for Intermediate/Poor-Risk RCC

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCC

PeerView Oncology

Key objectives in kidney cancer: treatment sequencing & refining clinical endpoints

Adjuvant therapy in RCC: harnessing prognostic information

Clinical Research and Meaningful Outcomes - What Are They And Why Do They Matter?

Whiteboard Medicine

In RCC, What Is the Optimal Treatment for Intermediate/Poor-Risk Disease?

GU Oncology Now

What is the best front line treatment for metastatic clear cell RCC in 2018?

Importance of Risk Assessment in Renal Cell Carcinoma

Immunotherapy for NMIBC: Emerging and Expanding Indications

Grand Rounds in Urology

Second-Line Treatment Options for RCC

GU Oncology Now

First-line treatment decision making for patients with RCC

Renal cell carcinoma

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC

PeerView Oncology

Management of Locally Advanced RCC (LND, IVC, Thrombus, Adjuvant, Neoadjuvant Therapy)

Clinical Hold in ALL Study, FDA Draft Guidelines, Expanded Approval in Hodgkin Lymphoma

Novel Therapeutic Strategies to Individualize Patient Care in RCC: Expert-Led Clinical Consults

PeerView Oncology

Immunotherapy in Renal Cell Carcinoma

UBC Urology Rounds